How to Prioritize Pediatric Populations in NASH Trials
PPD
JUNE 7, 2023
Food and Drug Administration (FDA) for approval , much work remains for drug developers aiming to advance treatments for pediatric populations. Reflecting Patient Diversity in NASH Trials Data from NASH clinical trials within adult populations may support clinical research into treatment for pediatric populations.
Let's personalize your content